Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12600229 | chr16:89859649 | C/T | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs12600466 | chr17:50306926 | A/T | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs12600551 | chr17:65792997 | C/T | 0.000423 | 178 | 24.5 | 34.37 | 8.22 | KM Plot |
PCPG | rs12600737 | chr17:50311547 | C/G | 6.48E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs12601842 | chr17:50271517 | G/A | 4.36E-5 | 174 | 25.53 | 29.7 | 14.43 | KM Plot |
PCPG | rs12601870 | chr17:50271674 | G/A | 4.36E-5 | 174 | 25.53 | 29.7 | 14.43 | KM Plot |
PCPG | rs12601960 | chr17:50289205 | G/T | 6.66E-5 | 177 | 25.77 | 27.95 | 14.47 | KM Plot |
PCPG | rs12616820 | chr2:241540110 | A/G | 4.53E-5 | 173 | 26.88 | 20.17 | 10.3 | KM Plot |
PCPG | rs12618914 | chr2:239070534 | G/A | 8.25E-5 | 170 | 29.43 | 18.2 | 13.22 | KM Plot |
PCPG | rs12619455 | chr2:239080149 | A/C | 2.67E-5 | 174 | 29.5 | 18.2 | 13.22 | KM Plot |
PCPG | rs12619511 | chr2:176139776 | T/C | 0.000139 | 175 | 25.28 | 28.47 | 6.62 | KM Plot |
PCPG | rs12619657 | chr2:241528011 | G/A | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs12620571 | chr2:241529079 | G/A | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs12620622 | chr2:241529215 | G/A | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs12623230 | chr2:239092893 | C/T | 3.1E-5 | 172 | 29.43 | 18.2 | 13.22 | KM Plot |